المؤلفون: Tura, S., Mandelli, F., Mazza, P., Pileri, S., Gherlinzoni, F., Bocchia, M., Zinzani, P. L., Fiacchini, M., Martelli, M., Papa, G., Antimi, M., Martelli, M. F., Grignani, F., Brunangelo FALINI, Calabresi, F., Ruggeri, E. M., Dammacco, F., Lauta, V. M., Lucarelli, G., Moretti, L.

المصدر: Scopus-Elsevier

مصطلحات موضوعية: Adult, Male, Lymphoma, Lymphoma, Non-Hodgkin, Prednisolone, Cytarabine, High-Grade, Adult, Antineoplastic Combined Chemotherapy Protocols, Bleomycin, Bone Marrow, Comparative Study, Cyclophosphamide, Cytarabine, Doxorubicin, Drug Administration Schedule, Female, Fluorouracil, Human, Lymphoma, High-Grade, Male, Methotrexate, Prednisolone, Prednisone, Survival Analysis, Vincristine, Survival Analysis, Drug Administration Schedule, Bleomycin, Methotrexate, Bone Marrow, Doxorubicin, Vincristine, Antineoplastic Combined Chemotherapy Protocols, Humans, Prednisone, Comparative Study, Female, Fluorouracil, Cyclophosphamide, Human

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::7507897b6566962c8dff4df24fed171b
https://pubmed.ncbi.nlm.nih.gov/1716338